Background Artificial intelligence methods in combination with the latest technologies,
including medical devices, mobile computing, and sensor technologies, have the potential to …

Recent advances in insulins, insulin pumps, continuous glucose‐monitoring systems, and
control algorithms have resulted in an acceleration of progress in the development of …

In this two-part Bench to Clinic narrative, recent advances in both the preclinical and clinical
aspects of artificial pancreas (AP) development are described. In the preceding Bench …

The artificial pancreas is a long-awaited goal for the management of type 1 diabetes, and its
development was recently triggered by the development of continuous glucose sensors …

From the outset, the child or adolescent with diabetes and relevant family members should
receive care from a multidisciplinary diabetes team comprised of specialists with training …

Abstract A novel Model Predictive Control (MPC) law for an Artificial Pancreas (AP) to
automatically deliver insulin to people with type 1 diabetes is proposed. The MPC law is an …

Objectives In the context of the gradual development of artificial intelligence in health care,
the clinical decision support systems (CDSS) play an increasing crucial role in improving the …

In the past decade diabetes management has been transformed by the addition of
continuous glucose monitoring and insulin pump data. More recently, a wide variety of …

For patients with type 1 diabetes, closed‐loop delivery systems (CLS) combining an insulin
pump, a glucose sensor and a dosing algorithm allowing a dynamic hormonal infusion have …

Introduction: Automated insulin delivery for people with type 1 diabetes has been a major
goal in the diabetes technology field for many years. While a fully automated system has not …